Effects of oral montelukast on airway function in acute asthma

Respiratory Medicine

Volumn 97, Issue 5, 2003, Pages 533-536

  Çýllý, Aykut ^a   Kara, A ^a   Ozdemir T ^a   Ogus C ^a   Gulkesen K H ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Acute asthma; Airway function; Montelukast

Indexed keywords

ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; MONTELUKAST; PLACEBO; PREDNISOLONE; STEROID; TERBUTALINE; TERBUTALINE SULFATE;

ACUTE DISEASE; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; DYSPNEA; FEMALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE;

EID: 0242417035     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2003.1479     Document Type: Article

References (20)

1. Barnes PJ, Jonsson B, Klim J. The costs of asthma. Eur Respir J 1996; 9: 636-642.
2. Salvi SS, Krishna MT, Sampson AP, et al. The anti-inflammatory effects of leukotriene-modifying drugs and their use in asthma. Chest 2001; 119: 1533-1546.
3. Barnes NC. Effects of antileukotrienes in the treatment of asthma. Am J Respir Crit Care Med 2000; 161: 73-76.
4. Reiss TF, Sorkness CA, Stricker W, et al. Effects of montelukast (MK-0476), a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids. Thorax 1997; 52: 45-48.
5. Marik PE, Varon J. Steroids in acute exacerbation of asthma. Chest 1999; 116:273-275.
6. Rodrigo G, Rodrigo C. Corticosteroids in the emergency department therapy of acute adult asthma. Chest 1999; 116: 285-295.
7. Linn RY, Pesola GR, Westfal RE, et al. Early parenteral corticosteroid administration in acute asthma. Am J Emerg Med 1997; 15(7): 621-625.
8. Strauss L, Hejal R, Galan G, et al. Obsevations on the effects of aerosolised albuterol in acute asthma. Am J Respir Crit Care Med 1997; 155: 454-458.
9. FitzGerald JM, Grunfeld A, Pare PD, et al. The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs nebulized adrenergic bronchodilator alone in acute asthma. Canadian Combivent Study Group. Chest 1997; 111: 311-315.
10. Fanta CH, Rossing TH, McFadden ER. Emergency room treatment of asthma. Am J Med 1982; 72:416-422.
11. Rossing TH, Fanta CH, McFadden ER, et al. A controlled trial of the use of single vs combined-drug therapy in the treatment of acute episodes of asthma. Am Rev Respir Dis 1981; 123: 190-194.
12. Hui KP and Barnes NC. Lung function improvement in asthma with cysteinyl leukotriene receptor antagonist. Lancet 1991; 337: 1062-1063.
13. Impens N, Reiss TF, Teahan JA, et al. Acute bronchodilation with an intravenously administered leukotriene D4 antagonist, MK-679. Am Rev Respir Dis 1993; 147: 1442-1446.
14. Israel E, Rubin P, Kemp JP, Grossman J, et al. The effect of inhibition of 5-lipoxygenase by zileuten in mild to moderate asthma. Ann Intern Med 1993; 119: 1059-1066.
15. 4) receptor antagonist (MK-571) in patients with asthma. Am Rev Respir Dis 1992; 146: 358-363.
16. Cheng H, Leff JA, Amin R, et al. Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females. Pharm Res 1996; 13: 445-448.
17. Singh SD, Allen DJ. Intravenous montelukast. Thorax 2000; 55: 1070.
18. Dockhorn RJ, Baumgartner RA, Leff JA, et al. Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, corossover study in asthmatic patients. Thorax 2000; 55: 260-265.
19. Pavord ID, Ward R, Woltmann G, et al. Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med 1999; 160: 1905-1909.
20. Kuilert LM, Barnes NC. Leukotriene receptor antagonists:useful in acute asthma? Thorax 2000; 55: 255-256